<DOC>
	<DOC>NCT01722591</DOC>
	<brief_summary>A prospective, multicenter, uncontrolled study to evaluate the safety and efficacy of the Cardiapex percutaneous trans-apical access and closure system. The Cardiapex device intended for percutaneous access and closure of the left ventricular apex in conjunction with transapical Transcatheter Aortic Valve Implantation (TAVI).</brief_summary>
	<brief_title>Safety and Efficacy Study of the Cardiapex Percutaneous Trans-apical Access and Closure System</brief_title>
	<detailed_description />
	<criteria>Patient scheduled for transapical TAVI Patient â‰¥ 70 years of age Patient able to give informed written consent Patient able to attend follow up examinations Scheduled concomitant nonTAVI cardiac procedure Patient with Left Ventricular Ejection Fraction (LVEF) &lt; 30% at time of enrollment Patient with known apical infarcted area Patient with a distinct large vessel right at the anatomical apex9 (based on preoperative coronary angiography Patients with known lung tissue surrounding the apex and possibly interfering with the inout puncture (based on preoperative gated CT assessment Patient with contraindications to transapical TAVI Patient's inability to tolerate or comply with normal postsurgical drug regimen Patient's inability to comply with required followups, including echocardiography Patient participation in other clinical trials within previous month</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>